Category: Biotechnology
The $27 million were raised in a Series-C financing with investors like Bristol-Myers Squibb and Bill & Melinda Gates Foundation participating in the round. The money would be utilized to advance the company’s microbiome-derived product candidates. Vedanta Biosciences, Inc. (Vedanta), a renowned PureTech Health affiliate, …
Relay Therapeutics, a privately-held biotechnology company based in Cambridge, Massachusetts, is currently in the news for securing $400 million in venture capital financing during a Series C funding round. The Series C funding, led by SoftBank Vision Fund, was participated in by new investors including …
Voluntis, a company specializing in digital therapeutics, has reportedly announced that it has formed a collaboration with research-based global biopharmaceutical company AbbVie, in order to improve patient care coordination in immunology through innovative digital therapeutic software. As per trusted sources, the companies will collectively leverage …
The U.S.-based global pharmaceutical firm Eli Lilly & Company, and California-based immunotherapy company, Aduro Biotech, are currently in the news for announcing a research collaboration, as well as an exclusive license deal, for the cGAS-STING pathway inhibitor program that would develop new immunotherapies for inflammatory …
Biotech firm Kineta has recently announced an agreement with pharmaceutical corporation Pfizer, which includes an upfront payment of $15 million and possibly an additional $505 million down the line. With this deal, Seattle-based Kineta, Inc. has certainly received a boost towards its efforts of killing …
Distributed Bio, which a global leader in computational optimization of fully human monoclonal antibody libraries, has recently made an announcement confirming a multi-target collaboration with Seattle-based Good Therapeutics Inc. According to BioSpace, Distributed Bio, under the partnership, would be using its SuperHuman antibody library platform …
Engineers at the renowned MIT Institute claim to have developed new antimicrobial peptides that fight bacteria causing respiratory diseases and other infections. These antimicrobial peptides are based on a naturally occurring peptide that is produced by the South American wasp. Incidentally, the venom of bees …
Australian scientists have recently unveiled that they have developed a simple 10-minute blood test that can diagnose cancer anywhere in the human body. Reportedly, the detection process is based on identifying a unique DNA structure that is usually present in all the type of the …
argenx SE, a Netherland-based biotechnology firm that develops a large range of differentiated antibody-based therapies for treating severe autoimmune diseases and cancer, has recently inked a deal with Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J), to develop …